Aldeyra Therapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2024
Filed with the SEC on Mar 28, 2025 and accepted by EDGAR at Mar 28, 2025, 17:19 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000950170-25-046946. Last ingested by Listed: Oct 24, 2026, 15:11 ET. Listed shows no prices and gives no investment advice.